Can Balversa be used to treat breast cancer? What we know from research, and what it means for you.

Toripalimab may get its EMA and MHRA approvals soon, but when will it be available to patients? All you need to know.

When will Tivdak be available to patients in Europe and the UK? All you need to know, and all your options to get the treatment quicker.

Zynyz is close to EMA approval, but it won't be immediately available everywhere in Europe. Here's how to get the treatment at your own timeline.

Erdafitinib may get its EMA approval in 2024, but when will it be available on the market?

Can tazemetostat treat bladder cancer, prostate cancer, and more? Here's the latest research.

Tazverik seems a long way from EMA approval. If you can't wait, here are all your options to safely get the treatment.

Stay updated on the latest psoriasis creams approved for children in 2024. Learn about the safest and most effective treatments available for your child's skin condition.

Get the latest updates on Tofersen's EMA approval timeline and discover alternative ways to access the medicine in the meantime.

When will Radicut/Radicava(edaravone) be available to ALS patients in Europe and the UK (and what to do in the meantime).

When is the first nasal spray for dry eyes coming to Europe (and what to do in the meantime)

Topical roflumilast isn't likely to be available in Europe soon. Here's what you can expect, and some solutions for the meantime.

How effective is adagrasib for brain metastases? The latest data, and how to access the treatment quickly.

Adagrasib is now approved in the EU. But it can still take some time until it's available. Here's what you can expect and your options in the meantime.

When are Elahere's EMA and MHRA approvals expected, and what can patients in Europe and the UK do in the meantime.

When will Leqembi receive MHRA approval? And how you can access the medicine in the meantime.

Ryzneuta's EMA and MHRA approvals seem nowhere in sight. Here's how you can access the medicine without waiting.

When will capivasertib be available to breast cancer patients in Europe and the UK? Approval status, timelines, and all your options for accessing the medicine quickly.

Everything you need to know about nitrogacestat's approval in Europe and the UK. Including all your options to access the medicine earlier.

What's after Enhertu? Some of the alternatives your doctor may consider if Enhertu starts working.

How does Herceptin compare to Enhertu? Find out the similarities and differences between these two treatments for HER2-positive cancer.

What is the age limit for ruxolitinib? Find out all about the potential use of Opzelura on children.

When is margetuximab's EMA and MHRA approval expected? And what are your options in the meantime?

Is reportrectinib getting EMA approval soon, and how can you access it in the meantime?

How effective is fruquintinib for lung cancer? The latest clinical trial results, and what they could mean for your treatment.

What is the fastest migraine relief medicine that you can get in Europe and the UK in 2023?

When can colorectal cancer patients in Europe and the UK expect to have access to Fruzaqla?

When will Ojjaara be available to myelofibrosis patients in Europe and the UK? And what you can do in the meantime.

What patients in Europe and the UK need to know about vamorolone's availability timeline.